Armata sets June 11, 2026 annual shareholder meeting
Armata Pharmaceuticals, Inc. has scheduled its 2026 annual meeting of stockholders for June 11, 2026 at 8:30 a.m. Pacific Time at its principal executive offices in Los Angeles, California.
Rhea-AI Filing Summary
Armata Pharmaceuticals, Inc. has scheduled its 2026 annual meeting of stockholders for June 11, 2026 at 8:30 a.m. Pacific Time at its principal executive offices in Los Angeles, California. Stockholders of record at the close of business on April 17, 2026 will be entitled to receive notice and vote at the meeting.
The company has set 5:00 p.m. Pacific Time on April 12, 2026 as the deadline for receipt of stockholder proposals and director nominations submitted under Section 2.6 of its Amended and Restated Bylaws. Proposals and nominations must be delivered in writing to the Corporate Secretary at Armata’s principal executive offices and must comply with the advance notice provisions in the bylaws.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 8.01 — Other Events
1 item
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
Annual meeting date: June 11, 2026
Record date: April 17, 2026
Proposal deadline: April 12, 2026, 5:00 p.m. PT
+2 more
5 metrics
Annual meeting date
June 11, 2026
Date of 2026 annual meeting of stockholders at 8:30 a.m. Pacific Time
Record date
April 17, 2026
Stockholders of record at close of business may vote at the meeting
Proposal deadline
April 12, 2026, 5:00 p.m. PT
Deadline for receipt of stockholder proposals and director nominations
Meeting time
8:30 a.m. Pacific Time
Scheduled start time for the 2026 annual meeting
Meeting location
5005 McConnell Avenue, Los Angeles, CA 90066
Principal executive offices where the meeting is scheduled
Key Terms
annual meeting of stockholders, stockholders of record, advance notice bylaw provisions, Amended and Restated Bylaws, +1 more
5 terms
annual meeting of stockholders financial
"Armata Pharmaceuticals, Inc. has set June 11, 2026 as the date for its 2026 annual meeting of stockholders"
stockholders of record financial
"Armata’s stockholders of record at the close of business on April 17, 2026, will be entitled to notice"
Stockholders of record are the people or entities whose names appear on a company's official shareholder list on a specific cutoff date set by the company or its transfer agent; only those listed are entitled to receive dividends, vote at shareholder meetings, or participate in other corporate actions. Think of it like a guest list for an event: being on the list on the set day determines who gets the benefits and rights, so investors must own shares before the cutoff to qualify.
advance notice bylaw provisions regulatory
"Stockholder proposals and nominations submitted pursuant to Armata’s advance notice bylaw provisions must also comply"
Amended and Restated Bylaws regulatory
"Section 2.6 of Armata’s Amended and Restated Bylaws for consideration at the Annual Meeting"
A company’s amended and restated bylaws are its internal rulebook rewritten to include all changes in one updated document, replacing the old bylaws. For investors, this matters because the bylaws set how the board, shareholders and officers make decisions, hold votes and handle disputes; a new consolidated version can change voting rights, control mechanisms or procedures that affect corporate governance and the value or risk of an investment.
proxy statement financial
"set forth in the Company’s proxy statement for the Annual Meeting"
A proxy statement is a document companies send to shareholders ahead of a meeting that lays out the items up for a vote—like who will sit on the board, executive pay, and major corporate decisions—and provides background so shareholders can decide how to cast their votes or appoint someone to vote for them. Think of it as an agenda plus a ballot and briefing notes, important because the outcomes can change control, strategy, and value.
FAQ
When is Armata Pharmaceuticals (ARMP) holding its 2026 annual meeting?
Armata Pharmaceuticals will hold its 2026 annual meeting of stockholders on June 11, 2026 at 8:30 a.m. Pacific Time. The meeting is scheduled to take place at the company’s principal executive offices in Los Angeles, California, as further detailed in its upcoming proxy statement.
Who is entitled to vote at Armata Pharmaceuticals (ARMP) 2026 annual meeting?
Stockholders of Armata Pharmaceuticals of record at the close of business on April 17, 2026 are entitled to vote at the 2026 annual meeting. This record date determines which stockholders may receive notice of the meeting and vote on matters presented.
What is the deadline to submit stockholder proposals for Armata Pharmaceuticals (ARMP) 2026 meeting?
The deadline for stockholder proposals and director nominations under Armata’s advance notice bylaw provisions is 5:00 p.m. Pacific Time on April 12, 2026. Submissions must be received in writing by the Corporate Secretary at the company’s principal executive offices.
Where will Armata Pharmaceuticals (ARMP) 2026 annual meeting be held?
Armata’s 2026 annual meeting is scheduled at its principal executive offices at 5005 McConnell Avenue, Los Angeles, California 90066. The company notes the meeting could be held at another time or location if its board determines and discloses this in the proxy statement.
What requirements apply to Armata Pharmaceuticals (ARMP) stockholder proposals and nominations?
Stockholder proposals and director nominations must comply with Section 2.6 of Armata’s Amended and Restated Bylaws. They must meet the advance notice provisions, be submitted in writing to the Corporate Secretary by the stated deadline, and may be omitted if they do not satisfy applicable requirements.
AI-generated analysis. How Rhea-AI works. Not financial advice.
